{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:28:23Z","timestamp":1793834903864,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical and Health Science and Technology Project of Zhejiang Province","doi-asserted-by":"crossref","award":["2024KY1535; 2025KY240"],"award-info":[{"award-number":["2024KY1535; 2025KY240"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07013-0","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T12:13:08Z","timestamp":1756815188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["CAFs promote immune evasion in gastric cancer through histone lactylation-mediated suppression of NCAPG ubiquitination"],"prefix":"10.1186","volume":"23","author":[{"given":"Sheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linmei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojian","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2150-3414","authenticated-orcid":false,"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"7013_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer Journal for Clinicians. 2021;71:209\u201349.","journal-title":"Ca-a Cancer Journal for Clinicians"},{"key":"7013_CR2","doi-asserted-by":"crossref","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al: Gastric Cancer, Version 2.2022. Journal of the National Comprehensive Cancer Network 2022, 20:167\u2013192.","DOI":"10.6004\/jnccn.2022.0008"},{"key":"7013_CR3","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/S1470-2045(24)00180-3","volume":"25","author":"M Svrcek","year":"2024","unstructured":"Svrcek M, Voron T, Andre T, Smyth EC, de la Fouchardiere C. Improving individualised therapies in localised gastro-oesophageal adenocarcinoma. Lancet Oncol. 2024;25:e452\u201363.","journal-title":"Lancet Oncol"},{"key":"7013_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","volume":"7","author":"JS Chao","year":"2021","unstructured":"Chao JS, Fuchs CS, Shitara K, Tabernero J, Muro K, Van Cutsem E, et al. Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials. JAMA Oncol. 2021;7:895\u2013902.","journal-title":"JAMA Oncol"},{"key":"7013_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"7013_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu DH. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:13.","journal-title":"Pharmacol Ther"},{"key":"7013_CR7","volume":"13","author":"YD Liu","year":"2022","unstructured":"Liu YD, Li CF, Lu YP, Liu C, Yang W. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front Immunol. 2022;13:17.","journal-title":"Front Immunol"},{"key":"7013_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41419-024-06744-0","volume":"15","author":"SS Qin","year":"2024","unstructured":"Qin SS, Guo QW, Liu Y, Zhang XG, Huang P, Yu HD, et al. A novel TGFbeta\/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression. Cell Death Dis. 2024;15:14.","journal-title":"Cell Death Dis"},{"key":"7013_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10:627\u201342.","journal-title":"Trends Cancer"},{"key":"7013_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"7013_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432:332\u20137.","journal-title":"Nature"},{"key":"7013_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18:16.","journal-title":"Mol Cancer"},{"key":"7013_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2019;16:282\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7013_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41416-019-0509-3","volume":"121","author":"KA Gieniec","year":"2019","unstructured":"Gieniec KA, Butler LM, Worthley DL, Woods SL. Cancer-associated fibroblasts-heroes or villains? Br J Cancer. 2019;121:293\u2013302.","journal-title":"Br J Cancer"},{"key":"7013_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","volume":"10","author":"E Helms","year":"2020","unstructured":"Helms E, Onate MK, Sherman MH. Fibroblast heterogeneity in the pancreatic tumor microenvironment. Cancer Discov. 2020;10:648\u201356.","journal-title":"Cancer Discov"},{"key":"7013_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.trecan.2019.09.010","volume":"5","author":"BA Pereira","year":"2019","unstructured":"Pereira BA, Vennin C, Papanicolaou M, Chambers CR, Herrmann D, Morton JP, et al. CAF subpopulations: a new reservoir of stromal targets in pancreatic cancer. Trends Cancer. 2019;5:724\u201341.","journal-title":"Trends Cancer"},{"key":"7013_CR17","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.7150\/ijbs.68484","volume":"18","author":"SY Peng","year":"2022","unstructured":"Peng SY, Li YJ, Huang MJ, Tang GN, Xie YM, Chen DC, et al. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. Int J Biol Sci. 2022;18:1912\u201332.","journal-title":"Int J Biol Sci"},{"key":"7013_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pharmthera.2019.107451","volume":"206","author":"TP Brown","year":"2020","unstructured":"Brown TP, Ganapathy V. Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and warburg phenomenon. Pharmacol Ther. 2020;206:17.","journal-title":"Pharmacol Ther"},{"key":"7013_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat Rev Cancer. 2017;17:577\u201393.","journal-title":"Nat Rev Cancer"},{"key":"7013_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc3110","volume":"11","author":"BA Webb","year":"2011","unstructured":"Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer. 2011;11:671\u20137.","journal-title":"Nat Rev Cancer"},{"key":"7013_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101197","volume":"79","author":"W Xu","year":"2024","unstructured":"Xu W, Zhou B, Wang P, Ma Y, Jiang Y, Mo D, et al. N6-methyladenosine modification of 3\u2019tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma. Drug Resist Updat. 2024;79:101197.","journal-title":"Drug Resist Updat"},{"key":"7013_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, et al. Lactate metabolism in human lung tumors. Cell. 2017;171:358.","journal-title":"Cell"},{"key":"7013_CR23","first-page":"11","volume":"23","author":"AL Krol","year":"2022","unstructured":"Krol AL, Nehring HP, Krause FF, Wempe A, Raifer H, Nist A, et al. Lactate induces metabolic and epigenetic reprogramming of pro-inflammatory Th17 cells. EMBO Rep. 2022;23:11.","journal-title":"EMBO Rep"},{"key":"7013_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1126\/sciadv.abi8602","volume":"7","author":"JT Noe","year":"2021","unstructured":"Noe JT, Rendon BE, Geller AE, Conroy LR, Morrissey SM, Young LEA, et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci Adv. 2021;7:12.","journal-title":"Sci Adv"},{"key":"7013_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41416-024-02735-2","volume":"131","author":"X Li","year":"2024","unstructured":"Li X, Xie GP, Chen J, Wang YH, Zhai J, Shen LZ. Tumour cell-derived serglycin promotes IL-8 secretion of CAFs in gastric cancer. Br J Cancer. 2024;131:271\u201382.","journal-title":"Br J Cancer"},{"key":"7013_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tem.2024.01.011","volume":"35","author":"ZJ Yang","year":"2024","unstructured":"Yang ZJ, Zheng YQ, Gao Q. Lysine lactylation in the regulation of tumor biology. Trends Endocrinol Metab. 2024;35:720\u201331.","journal-title":"Trends Endocrinol Metab"},{"key":"7013_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai PW, Xie MY, Ge SF, Ruan J, Fan XQ, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:21.","journal-title":"Genome Biol"},{"key":"7013_CR28","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1158\/0008-5472.CAN-23-0158","volume":"83","author":"KK Tsai","year":"2023","unstructured":"Tsai KK, Bae BI, Hsu CC, Cheng LH, Shaked Y. Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers. Cancer Res. 2023;83:2993\u20133000.","journal-title":"Cancer Res"},{"key":"7013_CR29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1158\/0008-5472.CAN-22-2496","volume":"83","author":"LH Cheng","year":"2023","unstructured":"Cheng LH, Hsu CC, Tsai HW, Liao WY, Yang PM, Liao TY, et al. Aspm activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression. Cancer Res. 2023;83:830\u201344.","journal-title":"Cancer Res"},{"key":"7013_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13046-024-03030-x","volume":"43","author":"J Chang","year":"2024","unstructured":"Chang J, Zhang YD, Zhou T, Qiao Q, Shan JJ, Chen YNL, et al. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated \u03b2-catenin signaling in cholangiocarcinoma. J Exp Clin Cancer Res. 2024;43:17.","journal-title":"J Exp Clin Cancer Res"},{"key":"7013_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203783119","volume":"119","author":"XX Wu","year":"2022","unstructured":"Wu XX, Xu SB, Wang PP, Wang ZQ, Chen HX, Xu XZ, et al. ASPM promotes ATR-CHK1 activation and stabilizes stalled replication forks in response to replication stress. Proc Natl Acad Sci U S A. 2022;119:12.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7013_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41419-020-02753-x","volume":"11","author":"LL Jiang","year":"2020","unstructured":"Jiang LL, Ren LL, Chen H, Pan JY, Zhang ZJ, Kuang XQ, et al. NCAPG confers trastuzumab resistance via activating SRC\/STAT3 signaling pathway in HER2-positive breast cancer. Cell Death Dis. 2020;11:12.","journal-title":"Cell Death Dis"},{"key":"7013_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/advs.202310037","volume":"11","author":"YL Hong","year":"2024","unstructured":"Hong YL, Chen Q, Wang ZN, Zhang Y, Li B, Guo HS, et al. Targeting Nuclear Receptor Coactivator SRC-1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD-L1. Advanced Science. 2024;11:18.","journal-title":"Advanced Science"},{"key":"7013_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.phrs.2018.08.004","volume":"135","author":"Y Xing","year":"2018","unstructured":"Xing Y, Mi CL, Wang Z, Zhang ZH, Li MY, Zuo HX, et al. Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1\u03b1 and STAT3. Pharmacol Res. 2018;135:166\u201380.","journal-title":"Pharmacol Res"},{"key":"7013_CR35","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41388-018-0497-4","volume":"38","author":"VC Pai","year":"2019","unstructured":"Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, et al. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-\u03b2-catenin signaling. Oncogene. 2019;38:1340\u201353.","journal-title":"Oncogene"},{"key":"7013_CR36","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1158\/0008-5472.CAN-14-1211","volume":"74","author":"A Pal","year":"2014","unstructured":"Pal A, Young MA, Donato NJ. Emerging potential of therapeutic targeting of Ubiquitin-Specific proteases in the treatment of cancer. Cancer Res. 2014;74:4955\u201366.","journal-title":"Cancer Res"},{"key":"7013_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/cdd.2016.53","volume":"23","author":"B Suresh","year":"2016","unstructured":"Suresh B, Lee J, Kim H, Ramakrishna S. Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ. 2016;23:1257\u201364.","journal-title":"Cell Death Differ"},{"key":"7013_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng XL, Niu MK, Zhu SL, Ge H, Wu KM. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21:27.","journal-title":"Mol Cancer"},{"key":"7013_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340.","journal-title":"Lancet"},{"key":"7013_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jep.2022.116030","volume":"304","author":"WB Shi","year":"2023","unstructured":"Shi WB, Wang ZX, Liu HB, Jia YJ, Wang YP, Xu X, et al. Study on the mechanism of Fufang E\u2019jiao Jiang on precancerous lesions of gastric cancer based on network pharmacology and metabolomics. J Ethnopharmacol. 2023;304:12.","journal-title":"J Ethnopharmacol"},{"key":"7013_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biopha.2021.111876","volume":"141","author":"JM Zhang","year":"2021","unstructured":"Zhang JM, Sun HH, Jiang KX, Song XZ, Wang XR, Yang YQ, et al. Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway. Biomed Pharmacother. 2021;141:10.","journal-title":"Biomed Pharmacother"},{"key":"7013_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati L, Carradori G, Scherz-Shouval R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat Rev Cancer. 2024;24:676\u201393.","journal-title":"Nat Rev Cancer"},{"key":"7013_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s43556-024-00233-8","volume":"5","author":"K Lv","year":"2024","unstructured":"Lv K, He T. Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets. Mol Biomed. 2024;5:70.","journal-title":"Mol Biomed"},{"key":"7013_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153965","volume":"15","author":"ZJ Hong","year":"2023","unstructured":"Hong ZJ, Xie W, Zhuo HQ, Wei XJ, Wang K, Cheng J, et al. Crosstalk between cancer cells and cancer-associated fibroblasts mediated by TGF- \u03b21-IGFBP7 signaling promotes the progression of infiltrative gastric cancer. Cancers. 2023;15:23.","journal-title":"Cancers"},{"key":"7013_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1053\/j.gastro.2017.03.046","volume":"153","author":"T Ishimoto","year":"2017","unstructured":"Ishimoto T, Miyake K, Nandi T, Yashiro M, Onishi N, Huang KK, et al. Activation of transforming growth factor beta 1 signaling in gastric cancer-associated fibroblasts increases their motility, via expression of rhomboid 5 homolog 2, and ability to induce invasiveness of gastric cancer cells. Gastroenterology. 2017;153:191.","journal-title":"Gastroenterology"},{"key":"7013_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.263","volume":"5","author":"Q Zhu","year":"2014","unstructured":"Zhu Q, Zhang X, Zhang L, Li W, Wu H, Yuan X, et al. The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression. Cell Death Dis. 2014;5:11.","journal-title":"Cell Death Dis"},{"key":"7013_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234613","volume":"15","author":"A Kogure","year":"2020","unstructured":"Kogure A, Naito Y, Yamamoto Y, Yashiro M, Kiyono T, Yanagihara K, et al. Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts. PLoS ONE. 2020;15:11.","journal-title":"PLoS ONE"},{"key":"7013_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbcan.2023.188999","volume":"1878","author":"S Kumari","year":"2023","unstructured":"Kumari S, Gupta R, Ambasta RK, Kumar P. Emerging trends in post-translational modification: shedding light on Glioblastoma multiforme. Biochimica Et Biophysica Acta-Reviews on Cancer. 2023;1878:30.","journal-title":"Biochimica Et Biophysica Acta-Reviews on Cancer"},{"key":"7013_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12935-023-03062-x","volume":"23","author":"YH Liu","year":"2023","unstructured":"Liu YH, Liu JW, Peng N, Hai SS, Zhang S, Zhao HB, et al. Role of non-canonical post-translational modifications in gastrointestinal tumors. Cancer Cell Int. 2023;23:18.","journal-title":"Cancer Cell Int"},{"key":"7013_CR50","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693\u2013705.","journal-title":"Cell"},{"key":"7013_CR51","doi-asserted-by":"publisher","first-page":"30628","DOI":"10.1073\/pnas.2009778117","volume":"117","author":"RA Irizarry-Caro","year":"2020","unstructured":"Irizarry-Caro RA, McDaniel MM, Overcast GR, Jain VG, Troutman TD, Pasare C. TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation. Proc Natl Acad Sci U S A. 2020;117:30628\u201338.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7013_CR52","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, Zheng L: H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer research 2024.","DOI":"10.1158\/0008-5472.c.7523017"},{"key":"7013_CR53","doi-asserted-by":"publisher","first-page":"T35","DOI":"10.1530\/ERC-14-0516","volume":"22","author":"R Pfoh","year":"2015","unstructured":"Pfoh R, Lacdao IK, Saridakis V. Deubiquitinases and the new therapeutic opportunities offered to cancer. Endocr Relat Cancer. 2015;22:T35\u201354.","journal-title":"Endocr Relat Cancer"},{"key":"7013_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1083\/jcb.202308099","volume":"223","author":"YW Huang","year":"2024","unstructured":"Huang YW, Luo G, Peng KS, Song Y, Wang YS, Zhang HT, et al. Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J Cell Biol. 2024;223:24.","journal-title":"J Cell Biol"},{"key":"7013_CR55","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.7150\/ijbs.91284","volume":"20","author":"QL Li","year":"2024","unstructured":"Li QL, Zhang FP, Wang H, Tong YM, Fu YN, Wu KJ, et al. NEDD4 lactylation promotes APAP induced liver injury through Caspase11 dependent non-canonical pyroptosis. Int J Biol Sci. 2024;20:1413\u201335.","journal-title":"Int J Biol Sci"},{"key":"7013_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K. The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114:16\u201324.","journal-title":"Cancer Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07013-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:26:22Z","timestamp":1756902382000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07013-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7013"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07013-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research was approved by the local ethics committee based on the Declaration of Helsinki. Written consent was obtained from each patient before surgery. Our research has received approval from the ethics committee of Affiliated Hospital with Jiangnan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the final version of the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest was declared by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"989"}}